ImmunityBio
In a classic case of "selling the news," shares of ImmunityBio, Inc. (NASDAQ: IBRX) took a sharp dive on Wednesday, March 4, 2026, plummeting over 13% to close at $9.02. The sell-off came as a surprise to many retail investors, especially considering that the drop coincided with
Piper Sandler
As the 2026 trading year kicks into high gear, Wall Street is closely watching the latest reshuffling of Piper Sandler’s influential 'Macro Select' model. After a stellar 2025 that saw the model outpace the broader market by a significant margin, Chief Investment Strategist Michael Kantrowitz has signaled
SEI Investments
On December 23, 2025, Piper Sandler (NYSE: PIPR) sent a clear signal to the market regarding the trajectory of the financial services sector by significantly upgrading its outlook for SEI Investments (NASDAQ: SEIC). Analyst Crispin Love moved the firm’s rating from Neutral to Overweight and raised the price target
Energy Sector
As the calendar turns toward 2026, the Exploration and Production (E&P) sector finds itself at a critical crossroads. On December 19, 2025, West Texas Intermediate (WTI) crude is trading near four-year lows, hovering between $55.70 and $56.40 per barrel. This slump, driven by a combination of